Sophisticated analytical technologies are complementing traditional approaches in the identification of residual process-related impurities of biotherapeutics.
Stuart Pengelley
Advertisement
Stuart Pengelley is the senior scientist, Biopharma Application Development for Bruker Daltonics.
Articles by Stuart Pengelley
Advertisement
Latest Updated Articles
Increasing the Depth and Reliability of HCP Analysis Using TIMS-MSPublished: July 15th 2021 | Updated:
Advertisement
Advertisement
